Unibest
← Back to patent-cliff list

Tirbanibulin

Tier C — Watch / trade

Tirbanibulin

Athenex Inc
Originator
2020
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Tubulin, SRC

Brand:Klisyri, KLISYRI

Indications (approved):Actinic keratosis

Regional status

US
Approved
2020-12-14
EU
Approved
2021-07-16
China
-
Japan
Phase III
2021-12-21

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 3 · Total yield 137 mg
KX-01-001622-40-2KX-01-002269409-70-3KX-01-003690636-28-3KX-01-004897016-93-2KX-01-005192642-83-4API · Tirbanibulin
CodeCAS No.Intermediate
KX-01-001622-40-22-morpholinoethan-1-ol
KX-01-002269409-70-34-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
KX-01-003690636-28-34-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
KX-01-004897016-93-2N-benzyl-2-(5-bromopyridin-2-yl)acetamide
KX-01-005192642-83-45-(5-bromopyridin-2(1H)-ylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione
OptimisedRoute 2Steps 5 · Total yield 60.16 g
KX-01-0063240-94-6KX-01-007106-41-2KX-01-008836-59-9KX-01-009351019-18-6KX-01-0101038395-62-8KX-01-0111038395-63-9KX-01-0121038395-64-0API · Tirbanibulin
CodeCAS No.Intermediate
KX-01-0063240-94-64-(2-chloroethyl)morpholine
KX-01-007106-41-24-bromophenol
KX-01-008836-59-94-(2-(4-bromophenoxy)ethyl)morpholine
KX-01-009351019-18-6(6-fluoropyridin-3-yl)boronic acid
KX-01-0101038395-62-84-(2-(4-(6-fluoropyridin-3-yl)phenoxy)ethyl)morpholine
KX-01-0111038395-63-92-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetonitrile
KX-01-0121038395-64-0methyl 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetate

Frequently asked questions

What are the approved indications of Tirbanibulin?

Approved indications include: Actinic keratosis.

When does the Tirbanibulin patent expire?

No public expiry year is available for Tirbanibulin yet; this page updates once verified.

How many synthesis routes are recorded for Tirbanibulin?

2 synthesis routes are recorded; the shortest is 3 steps with 137 mg total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Tirbanibulin intermediates?

All intermediates in Tirbanibulin routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Tirbanibulin intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29